MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)
Mieke Kriege, J.G.M. Klijn(Rotterdam University of Applied Sciences), Harry J. de Koning(Erasmus MC), C. Boetes(Radboud University Nijmegen), Emiel J. Rutgers(Oncode Institute), Cecile T.M. Brekelmans(Erasmus MC), Roland Holland(Radboud University Nijmegen), R. A. Manoliu(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jan C. Oosterwijk(University Medical Center Groningen), Rob A.�E.�M. Tollenaar(Leiden University Medical Center)
Cited by 50
Related Papers
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k